Gala Therapeutics CEO and leadership

Jonathan Waldstreicher, Principal, joined Apple Tree Partners in 2013 to invest in medical devices. After incubating an interventional pulmonary technology for two years, Jon founded Gala Therapeutics in Silicon Valley and assumed the CEO role to further its development. Prior to joining ATP, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where he initiated and led an investment strategy and R&D development program in a new growth platform technology area. He started at Johnson & Johnson as an Associate Director in the Corporate Office of Science & Technology where he executed numerous seed grants to startup companies and participated in technical diligence of venture capital investments. Before medical school, Jon worked in Equity Research at Bear Stearns. Jon received a B.A. from Brandeis University in Economics and an MD and MBA from Tufts University School of Medicine where he was awarded the Norman Stearns award for highest achievement and overall excellence within the dual degree program. He completed a General Surgery Internship at Tufts Medical Center in Boston.

I am a medical device executive with 22 years of broad-based experience in leadership, product development and operations with start-up, mid-size and Fortune 500 companies. My greatest asset lies in developing and leading a high performing, cross-functional organization that delivers new products or therapies to a marketplace. With experience across engineering, operations, clinical science and market development, I have successfully led companies to deliver novel therapies targeted at $1B+ markets. All of my past work has significantly contributed to “go to market” success, as well as the acquisition of prior companies by Fortune 500’s.

Jonathan Waldstreicher, Principal, joined Apple Tree Partners in 2013 to invest in medical devices. After incubating an interventional pulmonary technology for two years, Jon founded Gala Therapeutics in Silicon Valley and assumed the CEO role to further its development. Prior to joining ATP, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where he initiated and led an investment strategy and R&D development program in a new growth platform technology area. He started at Johnson & Johnson as an Associate Director in the Corporate Office of Science & Technology where he executed numerous seed grants to startup companies and participated in technical diligence of venture capital investments. Before medical school, Jon worked in Equity Research at Bear Stearns. Jon received a B.A. from Brandeis University in Economics and an MD and MBA from Tufts University School of Medicine where he was awarded the Norman Stearns award for highest achievement and overall excellence within the dual degree program. He completed a General Surgery Internship at Tufts Medical Center in Boston.